Log In
Print this Print this

dendrimer-trastuzumab, DEP-Trastuzumab

  Manage Alerts
Collapse Summary General Information
Company Starpharma Holdings Ltd.
DescriptionDendrimers -- polyvalent synthetic macromolecules -- loaded with trastuzumab
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today